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In this report, the interaction between respiratory syncytial virus (RSV) and heat shock protein 70 (HSP70) was examined. Although no
significant increase in total HSP70 protein levels was observed during virus infection, analysis of the HSP70 content in lipid-raft membranes
from mock- and virus-infected cells revealed an increase in the levels of raft-associated HSP70 during virus infection. Fluorescence
microscopy demonstrated that this transport of HSP70 into lipid-raft membranes correlated with the appearance of HSP70 within virus-
induced inclusion bodies. Furthermore, co-localisation of HSP70 with the virus N protein and the raft lipid GM1 was observed within these
structures. Immunoprecipitation experiments demonstrated the ability of HSP70 to interact with the virus polymerase complex in lipid-rafts in
an ATP-dependent manner. Collectively, these data suggest that RSV may induce cellular changes which allow the recruitment of specific
host-cell factors, via lipid-raft membranes, to the polymerase complex.
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Respiratory syncytial virus (RSV) infection can cause
severe bronchiolitis in infants and in certain high-risk groups
within the adult population, such as the elderly and
immunocompromised. The mature, infectious, RSV particle
comprises a ribonucleoprotein (RNP) core that is formed by
the interaction of the viral genomic RNA with the nucleo-
capsid (N) protein, the phosphoprotein (P) and the large (L)
protein. The minimal functional polymerase complex
requires an association of the N, P and L proteins (Collins
et al., 1996; Grosfeld et al., 1995; Yu et al., 1995) but an
additional virus protein, M2-1, is required for efficient
transcription of the virus genome by the polymerase complex0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.05.004
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E-mail address: r.sugrue@vir.gla.ac.uk (R.J. Sugrue).(Fearns and Collins, 1999; Hardy and Wertz, 1998; Hardy et
al., 1999; Mason et al., 2003). A lipid envelope, derived from
the host cell in which the virus glycoproteins are embedded,
surrounds the RNP. An additional virus protein, the matrix
(M) protein, which has been shown to regulate virus
transcriptional activity (Ghildyal et al., 2002; Rodriguez et
al., 2004), is located between the virus envelope and the RNP
(Arslanagic et al., 1996; Bachi and Howe, 1973; Brown et
al., 2002a; Norrby et al., 1970; Parry et al., 1979; Roberts et
al., 1995). During virus replication, the proteins that form the
polymerase complex are distributed both within virus
filaments and cytoplasmic inclusion bodies (IBs), with the
IBs being the major site of accumulation of these proteins in
the infected cell. The formation of IBs during virus infection
is a feature that is common to several different para-
myxoviruses, suggesting that these structures form an
integral part of the virus replication strategy.005) 69 – 80
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the virus polymerase complex have been increasingly
characterised (reviewed in Easton et al., 2004) and a
requirement for cellular protein factors for virus polymerase
activity has been demonstrated (Barik, 1992; Bitko et al.,
2003; Burke et al., 1998, 2000; Huang et al., 1993; Ulloa et
al., 1998). Recent evidence has suggested that during virus
replication, the virus polymerase associates with cellular
membranes that exhibit detergent-solubility properties that
are characteristic of lipid-rafts (Mason et al., 2004;
McDonald et al., 2004). In vitro studies have shown that
this membrane-association is not required for enzymatic
activity since the activity is retained following the mem-
brane solubilisation (Mason et al., 2004). However, this
membrane-association may play a role in the recruitment of
various factors that are required by the polymerase complex
during virus infection. This report demonstrates that at least
one host-cell factor, the chaperone heat shock protein 70
(HSP70), is recruited into lipid-raft membranes during virus
replication. Furthermore, this recruitment correlates both
with a direct interaction between HSP70 and the virus
polymerase complex within lipid-raft membranes and with
the association of HSP70 and IBs. Our results suggest that
cellular changes occur during RSV infection which allow
the transport of specific cellular factors to lipid-raft
membranes where the virus polymerase complex is located.Results and discussion
HSP 70 is recruited into lipid-raft membranes during virus
infection
The study of lipid-raft membranes from virus-infected
cells by two-dimensional nanoflow liquid chromatography
mass spectrometry (2D-nLC-MSMS) has been reported
previously (McDonald et al., 2004). Using this method,
the host-cell protein content of these structures was shown
to be qualitatively similar in both mock- and virus-infected
samples. However, the results did not indicate whether the
levels of these proteins changed upon virus infection and
therefore lipid-rafts from mock- and virus-infected cells
were analysed further in an attempt to quantitate these
protein levels. Total membranes were prepared from mock-
and virus-infected Hep2 cells and lipid-rafts prepared as
previously described using a flotation gradient (McDonald
et al., 2004). Following the 2D-nLC-MSMS analysis, the
host-cell protein content was examined in more detail by
comparing the abundance of identical peptides in the raft-
fractions from mock- and virus-infected cells. This analysis
showed that despite failing to detect the presence of
additional proteins following virus infection, at least one
host cell protein, HSP70, showed an increased abundance.
The 2D-nLC-MSMS analysis identified nine different
HSP70-specific peptides which were present in the lipid-
raft preparations from mock- and RSV-infected cells atsufficient levels and peak resolution to provide reliable data
and which showed good coverage of the HSP70 sequence
(Fig. 1A). The relative levels of these peptides in the mock-
and virus-infected cells were determined by comparing the
total ion count peak areas of extracted ion chromatograms
normalised to the total ion current (Figs. 1B and C). This
analysis showed an approximate four-fold increase of these
peptides in lipid-rafts prepared from virus-infected cells
compared with those from mock-infected cells, suggesting
an increased abundance of HSP70 in lipid-raft membranes
following virus-infection. An equivalent analysis of two
other cell proteins, PLAP and actin, showed no significant
differences between the two preparations (data not shown).
The increased abundance of HSP70 was confirmed by
the use of flotation gradient analysis to compare the levels of
lipid-raft-associated HSP70 in mock- and in virus-infected
cells (Figs. 2A and B). Total membranes from mock- and
virus-infected Hep2 cells were treated with 1% Triton X100
at 4 -C, fractionated using a sucrose flotation gradient, and
the individual fractions assayed for the presence of HSP70
by Western blotting. In mock-infected cells, high levels of
HSP70 were detected, but this was largely confined to the
non-raft fractions. Low levels of HSP70 were observed in
the lipid-raft fractions (Fig. 2A, highlighted by *) and these
results are consistent with a recent report that in non-
stressed cells, HSP70 can be detected in lipid-rafts (Broquet
et al., 2003). In virus-infected cells, as in mock-infected
cells, HSP70 was detected in the non-raft fractions.
However, in addition, HSP70 was readily detected in the
peak raft fractions (Fig. 2B, highlighted by *). The efficient
solubilisation of raft-associated proteins was confirmed by
comparing the relative distributions of transferrin receptor
(non-raft marker) and caveolin-1 (raft marker), which were
found almost exclusively in the non-raft and raft gradient
fractions respectively (Figs. 2C and D). Therefore, both the
mass spectrometry and flotation gradient analyses suggest
that during RSV-infection, there is an increase in the
association of HSP70 with lipid-rafts.
It seemed possible that the ability to detect the increased
abundance of HSP70 in lipid-rafts during RSV-infection
might arise from a generalised increase in HSP70 protein
levels during virus infection, which in turn may have
allowed the ease of detection of HSP70 in the raft fractions.
To discount this possibility, the total level of HSP70 in both
mock- and virus-infected cells was compared. In this
analysis, whole cell extracts were prepared from mock-
and RSV-infected cells and examined by Western blotting
using anti-HSP70 (Fig. 3A). This analysis showed that
similar levels of a single 70 kDa immunoreactive protein
species, the expected size for HSP70, were observed in both
mock- and RSV-infected cells. Thus, these data demonstrate
that following RSV-infection in Hep2 cells, HSP70 expres-
sion levels were not significantly elevated suggesting that
the detection of HSP70 in the lipid-raft fractions from virus-
infected cells was not a consequence of a generalised
increase in HSP70 expression levels following RSV
Fig. 1. Identification by mass spectrometry of sequences that match HSP70 in the lipid-raft fractions isolated from both mock- and RSV-infected cells. (A)
Sequence location of matched peptides within HSP70 identified by the 2D-nLC-MSMS analysis. The complete sequence of HSP70 (Accession no. CAB71335)
is shown and the peptide sequences identified by mass spectrometry (underlined bold type) are indicated. (B and C) Statistical analysis of HSP70-specific
peptides detected in lipid-rafts derived from mock- and virus-infected cells. (B) Examples of chromatograms obtained from two peptides, (a)
VTHAVVTVPAYFNDAQR and (b) TFAPEEISAMVLTK isolated from (M) mock- and (I) virus-infected cells are shown. (C) Summary of the statistical
analysis for all 11 peptides derived from HSP70 that were selected for analysis. Only peptides showing a significant individual ion score, where the top
sequence identified was from HSP70, were chosen.
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Fig. 3. Western blot analysis of mock- (M) and RSV-infected (I) Hep2 cells
at 30 h PI using (A) anti-HSP70 and (B) MAbNS2. The respective protein
bands are indicated, as are the positions of the molecular weight markers.
Fig. 2. Flotation gradient analysis of mock- and RSV-infected cell
membranes. Membranes were prepared from mock- and virus-infected
cells and examined by flotation gradient analysis as described in Materials
and methods. Specific proteins were located in gradient fractions by
Western blot analysis using relevant antibodies. The distribution of HSP70
in (A) mock- and (B) RSV-infected cells is shown. Also shown is the
distribution of the raft-marker caveolin-1 (cav-1) (C) and the non-raft
marker transferrin receptor (tfr) (D). 1 is the top fraction and 11 the bottom
fraction. The peak raft fractions are indicated (*).
G. Brown et al. / Virology 338 (2005) 69–8072infection. Furthermore, we failed to detect either an increase
in HSP70 expression levels or the appearance of higher
molecular mass forms of the protein during virus infection.
These phenomena are characteristic of the formation of the
heat shock-inducible forms of HSP70 suggesting that during
virus infection only the constitutively expressed form of the
HSP70 was detected. In this manuscript, the constitutive
form of protein will be referred to as HSP70. This is
consistent with the recent findings of Brasier et al. (2004)
who reported that in RSV-infected A459 cells, after an
initial increase in mRNA levels (12 h PI), the HSP70
mRNA levels fell during the later stages of the virus
replication cycle (16–24 h PI) to below those that were
present prior to infection.
HSP 70 associates with the virus-induced inclusion bodies
during infection
Confocal microscopy was used to determine whether or
not the change in raft-association of HSP70, observed in the
flotation gradient analysis, correlated with an alteration in
the cellular distribution of HSP70 during virus-infection.
The staining pattern of HSP70 and of several RSV proteins
located in IBs and virus filaments (e.g., the N, P and M2-1)
were compared. In addition, an immunological reagent that
specifically recognises the virus NS2 protein was used in
this analysis. The N protein is present within both virus
filaments and IBs, whereas the NS2 protein is detected
within IBs (Weber et al., 1995). The specificity of anti-N has
been demonstrated (Murray et al., 2001) and that of anti-
NS2, a previously unreported immunological reagent, was
demonstrated by Western blotting (Fig. 3B). This antibodyrecognises a single protein species of 16 kDa in virus-
infected cells, which is the reported size for the NS2 protein
(Evans et al., 1996). As expected, this protein was not
detected in mock-infected cells.
RSV-infected cells were labelled with anti-N and anti-
NS2 and the cellular distribution of each protein determined
(Figs. 4A–C). Staining of virus-infected cells showed the
presence of inclusion bodies (Fig. 4A) as has been described
previously (Garcia et al., 1993; Garcia-Barreno et al., 1996).
Although the inclusion bodies showed N protein staining
across their entirety, the interior of the IBs were more faintly
labelled compared to the periphery of the IBs where the
stain appeared to accumulate (Fig. 4A, inset), being similar
to the previously observed ‘‘o-rings’’ (Garcia et al., 1993).
This staining pattern allows two possibilities: either the
antibody failed to enter efficiently into the interior of the
inclusion body or the staining pattern reflected an increased
accumulation of the N protein at the periphery of the IB.
This interpretation differs from previously reported work in
which the IBs have been examined by electron microscopy.
These studies revealed that IBs exist as amorphous
structures capable of being labelled by antibodies against
the N, P, M2-1 and M proteins (Brown et al., 2002a, 2002b;
Garcia et al., 1993; Rixon et al., 2004) but did not provide
any evidence for an accumulation of the RNP-associated
proteins on the periphery of the IBs. However, a major
limitation of this type of approach is that these studies have
employed immuno-gold labelling of thin sections, which
allows only the detection of antigen exposed on the surface
of the section (Hermann et al., 1996). Therefore, an
appreciation of the distribution of the viral proteins in IBs
using thin sections may not be possible.
In contrast to the staining pattern observed for the N
protein, the NS2 antibody appeared to label across the entire
interior of the IB structure in a speckled manner. Although
the NS2 protein did not appear to be enriched at the
periphery of the IB, a small degree of co-localisation
between the N and NS2 proteins was seen at this location.
This can be seen more clearly in an image in which infected
Fig. 4. Examination of the N and NS2 protein distributions in virus-infected Hep2 cells by fluorescence microscopy. (A) Virus-infected cells were labelled with
anti-NS2 (green) and anti-N (red) and the distribution of each virus antigen visualised by confocal microscopy. An image from a single optical slice is shown.
The IBs are highlighted (white arrow) and insets show enlarged images of single IBs in the single-labelled and merged images. Also shown are mock-infected
cells labelled with anti-NS2. (B) Distribution of the NS2 and N protein within IBs in virus-infected cells viewed in cross-section. The images are reconstructed
from a z-stack series of images. The distribution of the N protein (red) in relation to the NS2 protein (green) can be seen. The IBs and virus filaments (VF) are
highlighted (white arrow). (C) Distribution of the N (red) and NS2 (green) proteins in a single IB shown by densitometry. Low levels of co-localisation between
the N and NS2 proteins can be seen as a yellow staining pattern in the merged images. (D) Distribution of the P and M2-1 proteins within IBs.
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section (Fig. 4B). In this case, a speckled pattern throughout
the IB can be seen for the NS2 protein, which contrasts with
the peripheral staining of the N protein within the IBs.
Additionally, analysis of the staining pattern of the N and
NS2 proteins by densitometry across a single IB, using the
LSM510 software, shows clearly the different distributions
of these proteins within the IB (Fig. 4C). The ability to label
the entire IB structure with anti-NS2 suggests that the
antibody is able to permeate the interior of the IB and the
pattern of staining for the N protein may reflect a protein
concentration gradient across the IB. A similar type of
staining pattern was also observed for the P and M2-1
proteins (Fig. 4D), suggesting that these proteins may,
likewise, exhibit a concentration gradient across the IB.
The cellular distribution of HSP70 in mock- and virus-
infected cells was compared (Fig. 5A). In mock-infectedcells labelled with anti-HSP70, a diffuse staining pattern
across the whole cell was observed. However, in virus-
infected cells, this staining pattern was also observed, but a
second staining pattern was detected in which HSP70
appeared to be sequestered within structures that resemble
IBs (Fig. 5A, highlighted by white arrows). This observa-
tion is consistent with recent observations where HSP70
appeared to cluster within the cytoplasm of virus-infected
A459 cells (Brasier et al., 2004).
The distribution of HSP70 was compared with that of the
major RNP-associated proteins, namely the N and P
proteins, by examining their staining patterns in virus-
infected cells (Figs. 5A and B). HSP70 and the N and P
proteins co-localised within the IBs. In addition, anti-HSP70
showed an increase in staining around the periphery of the
IBs, as described above for the N protein. Only staining of
IBs was observed and no evidence was obtained that HSP70
Fig. 5. The distribution of HSP70 in mock- and virus-infected Hep2 cells. Virus-infected cells were labelled with anti-HSP70 and either (A) anti-N or (B) anti-P
and the distribution of each antigen visualised by confocal microscopy. The appearance of localised, circular, cytoplasmic HSP70 concentrations is highlighted
(white arrows). Also shown are mock-infected cells labelled with anti-HSP70. (C) Virus-infected cells were labelled with anti-N (green) prior to staining with
oil-red O (ORO) (red). (D) Distribution of ORO and the N protein within virus-infected cells when viewed in cross-section. Co-localisation between ORO and
the N protein is shown by the yellow staining pattern in the merged images. (E) Virus-infected Hep2 cells were incubated at 33 -C with CTX-B-FITC (to detect
GM1) and processed for fluorescence microscopy using procedures described previously (Brown et al., 2002b). The treated cells were then labelled with anti-
HSP70. The distribution of HSP70 (red) and CTX-B-FITC (green) can be seen and the IBs are highlighted (white arrows). Co-localisation is shown by the
yellow staining pattern in the merged images. (F) Actin is present within IBs. Virus infected cells were labelled with anti-N and anti-h actin and the distribution
of each antigen visualised. Inset, an enlarged image of a single IB. The presence of the circular staining actin pattern in the IB is highlighted by white arrows.
G. Brown et al. / Virology 338 (2005) 69–8074was present in virus filaments (Brown and Sugrue, data not
shown). These data show that during virus-infection, HSP70
is recruited to the sites of accumulation of the major virus
structural proteins, i.e., the IBs.The correlation between HSP70 distribution in the cell
and the increased association with lipid-raft membranes
suggested that HSP70 was recruited to lipid-rafts present
within IBs. The presence of lipids within the IBs can be
G. Brown et al. / Virology 338 (2005) 69–80 75demonstrated using the lipid-specific stain, oil-red-O (ORO).
This stain is able to detect the accumulation of a variety of
different lipids, such as triacylglycerol and cholesterol-
esters, in cells. RSV-infected cells were labelled with anti-
N prior to staining with ORO (Fig. 5C) as described in
Materials and methods. Labelling with anti-N showed, as
expected, the presence of IBs and these structures were
readily stained with ORO, which can be seen more clearly
when the stained cells are viewed in cross-section (Fig. 5D).
In a further analysis, cholera toxin B subunit conjugated
to FITC (CTX-B-FITC) was used as a probe to detect the raft
lipid, GM1, within the cell. The exposure of cells to CTX-B-
FITC under normal culturing conditions allows the internal-
isation of CTX-B-FITC (Le and Nabi, 2003; Lencer et al.,
1992, 1995, 1999) and hence the detection of internal
membranes containing GM1. Virus-infected cells were
exposed to CTX-B-FITC under these conditions as described
previously (Brown et al., 2002b), after which the cells were
fixed and then labelled with anti-HSP70 (Fig. 5E). In this
way, the distributions of GM1 and HSP70 were compared
within the same cell. GM1 (green) and HSP70 (red)
exhibited strong co-localisation within IBs, thus providing
cytological evidence for an association of HSP70 and GM1
within IBs.
Actin is required for efficient RSV RNA polymerase
activity (Burke et al., 1998; Huang et al., 1993) and this host
factor has been detected in membrane fractions that are
enriched in the virus polymerase complex (Mason et al.,
2004; McDonald et al., 2004). We have previously examined
RSV-infected cells using phalloidin-FITC (Brown et al.,
2002a), a reagent that stabilises actin filaments by binding to
the filamentous form of actin (F-actin). Using fluorescence
microscopy, the FITC-conjugated form of phalloidin thus
allows visualisation of the F-actin distribution in the cell. In
this previous analysis, we failed to detect actin staining of
either the virus filaments or IBs. However, phalloidin-FITC
binds specifically to F-actin and therefore fails to detect other
forms of actin, such as globular actin (G-actin), which are
also in abundance within the cell. The distribution of actin
was therefore examined in infected cells by using an actin
antibody whose specificity has been demonstrated in RSV-
infected cells (McDonald et al., 2004). Virus-infected cells
were labelled with anti-N and anti-actin and the distribution
of each antigen visualised by fluorescence microscopy (Fig.
5F). This analysis revealed the presence of actin within the
periphery of the IBs providing evidence that host factors that
are known to be required for efficient virus polymerase
activity are also associated with these structures.
Evidence for an association between the RSV polymerase
complex and HSP70
The role played by HSP70 during RSV replication is
currently unclear but a role for the protein in the life cycle of
several viruses is well established (reviewed in Mayer,
2004). In particular, the recruitment of HSP70 to the sites oftranscriptional activity has been shown for several viruses
(e.g., herpesviruses, Ohgitani et al., 1998). Previous studies
of two paramyxoviruses, measles virus (MV) and the
closely-related canine distemper virus (CDV), have pro-
vided evidence for an interaction between the N protein and
HSP70 (Oglesbee et al., 1989, 1993, 1996; Zhang and
Oglesbee, 2003; Zhang et al., 2002), suggesting a possible
interaction between HSP70 and the polymerase complex of
these viruses. In these cases, HSP70 has been shown to
stimulate virus polymerase activity in vitro (Oglesbee et al.,
1996; Zhang et al., 2002). It is not clear if HSP70 acts
directly as a cofactor in this enzymatic process or if, by
binding to the N protein, it allows the N protein, and hence
the RNP complex, to fold into a favourable conformation
for polymerase activity during virus infection.
The fluorescence microscopy results described above
demonstrated a co-localisation between HSP70 and the N
protein within IBs and suggested that an interaction may
take place between the RSV polymerase complex and
HSP70. To examine this possibility, lipid-raft membranes
were isolated from mock- and virus-infected cells in the
presence (Fig. 6A) or absence (Fig. 6B) of apyrase and
subsequently solubilised with non-ionic detergents (1%
NP40, 60 mM octyl-h-glucoside). The membrane samples
were then immunoprecipitated with anti-N or with a
negative control antibody, anti-c-myc and the immunopre-
cipitates transferred by Western blotting on to PVDF
membranes. These membranes were then probed with
anti-HSP70 to determine the presence of HSP70 (Figs.
6A, a). The results showed a significant level of HSP70 in
samples which were immunoprecipitated from virus-
infected cells but not from mock-infected cells. In addition,
probing of the membranes with the relevant antibodies
revealed the presence of the N, P and M2-1 proteins in the
immunoprecipitation assays from virus-infected cells (Figs.
6A, b–d), indicating, as expected, that the various compo-
nents of the virus polymerase complex co-immunoprecipi-
tated with the N protein. These proteins were not detected in
samples that were immunoprecipitated with anti-c-myc or in
lysates prepared from mock-infected cells.
The ability to detect HSP70 in the N protein immuno-
precipitation assays was dependent upon the presence of
apyrase, an enzyme that promotes the dephosphorylation of
ATP to ADP and AMP. In the absence of apyrase, the N
protein, together with the other virus polymerase-associated
proteins, was observed in the immunoprecipitation assays,
whereas HSP70 was not detected (Fig. 6B). Apyrase has
been used in the analysis of the interaction between the
CDV N protein and HSP70 to demonstrate that this is
reversible and ATP-dependent (Oglesbee et al., 1996). In
these studies, it was envisaged that apyrase stabilised the
interaction between the N protein and HSP70, which
dissociates in the presence of ATP. The requirement for
apyrase suggests also that the interaction between the RSV
polymerase complex and HSP70, as in the case of CDV, is
both reversible and ATP-dependent.
Fig. 7. Inhibition of RSV polymerase activity by anti-HSP70. The RNA
polymerase activity in lipid-raft membranes was performed as described
previously (McDonald et al., 2004). Lipid-raft membranes from RSV-
infected cells were preincubated for 30 min at 4 -C with various
concentrations of anti-HSP70 prior to the addition of the polymerase
reaction mixture. The polymerase reactions were performed at 37 -C for 45
min and the incorporation of [a-32P]UTP into newly synthesised RNA
measured. The polymerase activity is expressed as a fraction of that
recorded in the absence of anti-HSP70. Each point on the graph represents
the average of 3 individual assays and the standard error within each
triplicate assay was less than 5%.
Fig. 6. HSP70 interacts with the RSV polymerase complex within lipid-rafts. Lipid-raft membranes were harvested from (M) mock- and (I) RSV-infected cells
in the presence (A) or absence (B) of apyrase. The raft-membrane samples were solubilised with an equal volume of 2% NP40/120 mM octyl-h-glucoside.
Aliquots of the solubilised proteins were incubated with protein-A-Sepharose beads (50% slurry) charged either with anti-N (N) or anti-c-myc (C) and
incubated o/n at 4 -C. The resin was washed extensively with PBSA +1% Triton X100 at 4 -C and the proteins eluted in boiling mix at 100 -C for 10 min. The
proteins were separated by SDS-PAGE and transferred by Western blotting on to PVDF membranes as described in Materials and methods. The membranes
were then probed with the relevant antibody (a) anti-HSP70, (b) anti-N, (c) anti-P and (d) anti-M2-1.
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between HSP70 and the virus polymerase complex. How-
ever, the possibility existed that this interaction may be a
consequence of the recruitment of HSP70 to sites of virus
protein expression, perhaps to facilitate correct folding of
the newly expressed proteins. Alternatively, it seemed
possible that HSP70 could play a direct role in the
enzymatic process of the polymerase complex, e.g., acting
as a cofactor. Evidence for a direct role was provided by
antibody inhibition studies, in which the in vitro effect of
anti-HSP70 on virus polymerase activity was examined
(Fig. 7). In this analysis, the raft-membranes were pre-
incubated with various concentrations of anti-HSP70 prior
to assaying for polymerase activity (McDonald et al., 2004).
Following the addition of anti-HSP70, a reduction in
polymerase activity greater than 50% was observed. In
contrast, no significant inhibition in the RNA polymerase
activity was observed when the anti-HSP70 was replaced by
the addition of equivalent concentrations of either BSA or
anti-mouse IgG (data not shown). This finding is similar to
that reported previously for CDV and MV and suggests that
binding of the antibody to HSP70 may block its interaction
with the RSV polymerase complex.
In this analysis, anti-HSP70 concentrations lower than 10
Ag/ml resulted in an approximate 10% increase in polymer-
ase activity. This stimulation was not observed when the
raft-membranes were incubated with equivalent concentra-
tions of anti-mouse IgG, and the reason for this apparent
stimulation in polymerase activity is unknown.
The recruitment of HSP70 into lipid-rafts in response to a
variety of different cell stresses has been reported. These
stresses include not only heat-shock, but also otherconditions such as calcium depletion in the ER and
perturbation of protein trafficking. It is envisaged that under
conditions of cell stress, heat shock proteins are transported
to the cell surface and subsequently secreted by a
mechanism that employs lipid-rafts (Broquet et al., 2003).
The data show that during RSV-infection, there appears to
be a recruitment of HSP70 into lipid-raft membranes that
correlates with its redistribution into IBs. The increased
abundance of HSP70 in lipid-rafts may arise due to an
alteration in the biochemical properties of the secretory
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in close proximity to the early compartments of the
secretory pathway (McDonald et al., 2004). The direct
association of HSP70 with RSV proteins appears to be
specific to IBs and no evidence was obtained to suggest that
HSP70 was present at the sites of virus assembly (Brown
and Sugrue, unpublished observations), which also involve
lipid-raft membranes (Brown et al., 2002a, 2002b, 2004;
Jeffree et al., 2003; McCurdy and Graham, 2003). This
suggests that HSP70 may play a role during virus-infection
that relates specifically to IBs.
The precise mechanism involved in the recruitment of
HSP70 into IBs during RSV infection is uncertain. It is
possible that recruitment is mediated by host factors, as yet
unidentified, or that the process is mediated directly by an
interaction between HSP70 and components of the virus
polymerase complex. In the case of MV, structural studies
on the C-terminal domain of the N protein suggest that it is
intrinsically disordered and requires an interaction with a
partner protein for proper folding (Bourhis et al., 2004;
Karlin et al., 2003; Longhi et al., 2003). The binding sites of
both the P protein and HSP70 have been mapped to this
region of the N protein (Bankamp et al., 1996; Zhang et al.,
2002). In the case of the MV N protein, HSP70 has been
shown to bind directly to a linear, twenty-four amino acid
sequence within this protein (Zhang et al., 2002). This
region contains the sequence VYNDRNLL, which con-
forms to one of the consensus sequences (VYxxR/KxLL,
where x is any amino acid) present within certain proteins
that interact with HSP70 (Zhang et al., 2002). Such an
association may induce folding of this intrinsically disor-
dered region of the N protein and hence influence the
activity of the polymerase complex during virus infection.
The interaction between the RSV N and P proteins has
been mapped to the C-terminus of the N protein (Garcia-
Barreno et al., 1996; Khattar et al., 2000) and it is likely that
the interaction between the N and P proteins will have similar
consequences for RSV to those described for MV. However,
the role played by HSP70 during RSV replication requires
further investigation and the nature of the interaction needs to
be characterised further. The various components which
constitute the polymerase complex of MV and RSV differ
significantly (e.g., the physical properties of the RSVandMV
Nproteins, Bhella et al., 2002). It is possible therefore that the
mechanism by which HSP70 and the RSV polymerase
complex interacts will differ in detail from that of MV. For
example, the HSP70 binding sequence motif described above
is not present in the N, P or M2-1 protein sequences from the
RSV A2 isolate and a unique motif may be present within
these RSV proteins that allows them to interact with HSP70.
Additionally, this interaction may involve all the proteins
within the polymerase complex rather than any one specific
protein as suggested by the MVand CDV data.
It is not clear to what extent other cell factors may
interact with the RSV polymerase complex and it is possible
that additional host cell proteins, which are as yetunidentified, may mediate the interaction with HSP70. A
recent analysis of the transcriptase complex of vesicular
stomatitis virus revealed the presence of elongation factor-
1a as well as HSP60 (Qanungo et al., 2004). Such findings
in a related paramyxovirus suggest that additional host cell
factors may also interact with the RSV polymerase complex.
Although the nature of the interaction between the
polymerase complex and HSP70 remains to be character-
ised, the association of the replication complex with HSP70,
and the appearance of HSP70 in IBs during virus-infection,
lends further support to the possibility that IBs may
represent sites of transcriptional activity. In addition, our
data suggest that virus-induced changes in lipid-raft
membranes may assist in the recruitment of cellular factors
by RSV.Materials and methods
Cells and viruses
The RSVA2 strain was used throughout this study. Hep2
cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum
(FCS) and antibiotics.
Antibodies and stains
The N, P and M2-1 protein antibodies were obtained from
Paul Yeo (MRC Virology Unit, Glasgow, UK). The NS2
protein monoclonal antibody (anti-NS2) was prepared as
follows. A branched peptide (NS2112–124), corresponding to
the C-terminal 13 amino acids (KHTPIIYKYDLNP) of the
RSVA2 strain, was synthesised on tetravalent (Lys)2-Lys-h-
Ala-Wang resin (Novochem) using standard 9-fluorenylme-
thoxycarbonyl-solid phase chemistry using an Advanced
ChemTech 348 V automated peptide synthesiser. The
resulting peptide, NS2112–124, was coupled to a mouse T-
cell epitope from sperm whale myoglobin, (sequence,
NKALELFRKDIAAKYKE) using standard procedures.
This peptide was used to immunise Balb/c mice and
monoclonal antibodies were prepared using standard proto-
cols. The tissue culture medium was harvested from anti-
NS2-expressing hybridoma cells, concentrated and filtered
through a 0.2-Am filter prior to use. The caveolin-1 (N20),
HSP70, anti-h actin and transferrin receptor (tfr) antibodies
were purchased from Santa Cruz Biotechnology, Trans-
duction Laboratories, Sigma-Aldrich and Zymed Laborato-
ries respectively.
The oil-red O and cholera toxin B subunit conjugated to
FITC (CTX-B-FITC) were purchased from Sigma Aldrich.
Western blotting
Western blotting was performed as described previously
(Brown et al., 2002a). Briefly, proteins were separated by
G. Brown et al. / Virology 338 (2005) 69–8078SDS PAGE after which they were transferred by Western
blotting on to PVDF membranes. The membranes were
washed, blocked with 1% Marvel +0.05% Tween and
probed with specific primary antibodies for 1 h. The
membranes were then washed, probed either with goat
anti-mouse or anti-rabbit IgG (whole molecule) peroxidase
conjugate (Sigma) as appropriate and the protein bands
visualised using the ECL protein detection system (Amer-
sham). Apparent molecular masses were estimated using
Rainbow protein markers (Amersham) in the molecular
weight range 14.3–220 kDa.
Immunofluorescence
Cells were seeded on 13 mm glass coverslips and either
mock- or RSV-infected and incubated at 33 -C for 30 h. The
cells were fixed with 3% paraformaldehyde (PFA) in PBS
for 30 min at 4 -C and incubated for 1 h at room temperature
with the primary antibody, washed and then incubated for a
further 1 h with goat anti-mouse IgG (whole molecule)
conjugated to either FITC or Cy5 (1/100 dilution). The
stained cells were mounted on slides with Citifluor and
visualised using a Zeiss Axioplan 2 confocal microscope.
The images were processed using LSM 510 v2.01 software.
Staining of GM1 using cholera toxin-B subunit (CTX-B-
FITC) was performed as described previously (Brown et al.,
2002b). Briefly, CTX-B-FITC was added to cells (diluted (1/
250) in PBSA) for 1 h at 33 -C. The cells were washed with
PBSA and then fixed in PFA prior to antibody labelling.
Oil-red O staining of cells was performed as described
previously (Hope and McLauchlan, 2000). After labelling of
cells with relevant antibodies, the coverslips were briefly
rinsed in 60% propan-2-ol followed by incubation with 0.5
ml of 60% propan-2-ol containing 1% oil-red O for 1.5–2
min at room temperature. The coverslips were then briefly
rinsed with 60% propan-2-ol, washed with PBS and H2O
and mounted on slides using Citifluor.
Flotation gradient analysis of detergent-insoluble lipid-raft
membranes
This was performed as described previously (Rixon et
al., 2004). Briefly, Hep2 cells were Dounce homogenised in
10 mM Tris pH 7.4/1 mM MgCl2 in the presence or absence
of 10 U/ml apyrase (Sigma) supplemented with an EDTA-
free protease-inhibitor mixture (Roche Molecular Biochem-
icals) at 4 -C. Total cell membranes were harvested by
centrifugation and resuspended in 1% Triton X-100, 2 mM
EDTA in PBS for 1.5 h at 4 -C. The solubilised membranes
were made up to a final concentration of 40% (w/v) sucrose
in 10 mM Tris pH 7.4/150 mM NaCl/1 mM EDTA (TNE),
placed at the bottom of a centrifuge tube and overlayed
successively with 7 ml 35% sucrose and 2 ml 5% sucrose in
TNE. After centrifugation at 210,000g for 18 h, the
gradient was fractionated and the individual fractions
analysed by Western blotting using appropriate antibodies.Protein determination
Protein concentrations were determined using the 2-D
Quant Kit (Amersham Biosciences).
Two-dimensional nanoflow liquid chromatography mass
spectrometry (2D-nLC-MSMS)
This was performed essentially as described previously
(McDonald et al., 2004). Briefly, the lipid-raft fraction was
harvested from the flotation gradient and precipitated in 6%
TCA, 60 mM sodium deoxycholate (final concentrations).
The pellets were resuspended at a concentration of
approximately 5 mg/ml in 100 mM Tris pH 7.5 containing
1% octyl-h-glucoside, 6 M urea and 2 M thiourea and
solubilised by sonication (4  30 s) with vigorous mixing.
The solution was then diluted nine-fold with ammonium
bicarbonate containing the appropriate amount of trypsin
and the protein digested overnight at 37 -C (Promega
modified sequencing grade, porcine, 20 Ag per 500 Ag of
raft protein) in 20 mM ammonium bicarbonate. The samples
were acidified with 5% formic acid and cleared by
centrifugation (10,000g, 10 min). Approximately 200 Ag
of solubilised protein was applied to a 2D-nLC-MSMS
system (Ultimate, standard configuration, Dionex) con-
nected to a QStar Pulsari electrospray mass spectrometer
via a nanoflow source (Protana). Mass spectrometric
analysis was performed in IDA mode (AnalystQS software,
Applied Biosystems), selecting the four most intense ions
for MSMS analysis. A survey scan of 400–1500 Da was
collected for 3 s followed by 5 s MSMS scans of 50–2000
Da using the standard rolling collision energy settings.
Masses were then added to the exclusion list for 3 min.
For identification purposes, peaks were extracted and
searched using the Mascot Daemon 2.0 (Matrix Science)
search engine and assigned a probability-based Mowse
score (Perkins et al., 1999). Extracted ion chromatograms
were generated manually in AnalystQS with a 0.2-Da
window and peak areas measured using the TurboChrom
software (Applied Biosystems) and then normalised
between samples based on the total ion count of the
complete peptide elution region of the corresponding
chromatographic trace.Acknowledgments
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